FDA Issues Aptivus (tipranavir) Warning
Tuesday July 4, 2006
The Food and Drug Administration along with HIV drug manufacturer Boehringer Ingelheim has issued a new black box warning for the drug Aptivus (tipranavir). The manuafacturer has reported a number of patients who suffered from intracranial bleeding while taking Aptivus. Read more....
Related items...


Comments
No comments yet. Leave a Comment